Status:
RECRUITING
Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS)
Lead Sponsor:
Thammasat University
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine efficacy of FMT via rectal enema and encapsulated FMT in patients with IBS in Thailand. The main question it aims to answer is: • Does FMT provide bett...
Detailed Description
Irritable bowel syndrome (IBS) is a common functional bowel disorder defined by recurrent abdominal pain related to defecation or a change in bowel habit (1). Pathogenic mechanisms of IBS include gut ...
Eligibility Criteria
Inclusion
- Patients aged 18-70 years with IBS diagnosed by Rome IV criteria
- Patients who can provide written informed consent.
Exclusion
- Pregnant or breastfeeding women
- Severe comorbidities: chronic kidney disease (GFR\<15 ml/min), cirrhosis, cancer, etc.
- Fecal incontinence
- Immunocompromised patients
- Taking probiotic, or fermented food
- Discontinue medication for IBS \<1 month prior to study inclusion
Key Trial Info
Start Date :
August 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 19 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06201182
Start Date
August 19 2020
End Date
August 19 2024
Last Update
April 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thammasat University
Pathum Thani, Thailand, 12120